Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease. | Canada Hyperbarics Skip to main content
Clinical Study Journal of clinical immunology 1997

Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease.

Weisz G, Lavy A, Adir Y, Melamed Y, Rubin D, Eidelman S, et al. — Journal of clinical immunology, 1997

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated the effect of daily hyperbaric oxygen treatment on IL-1, IL-6, and TNF-alpha secretion by circulating monocytes in seven patients with perianal Crohn's disease over one month.

What They Found

Pretreatment cytokine levels were elevated in patients compared to 10 age-matched controls. During the first 7 days of 20 HBO sessions, levels of IL-1, IL-6, and TNF-alpha in LPS-stimulated monocytes decreased, while serum IL-1 initially rose then fell, remaining low for the first week. After completing therapy, cytokine levels increased back to pretreatment values.

Canadian Relevance

There is no direct Canadian connection identified for this study.

Study Limitations

A significant limitation of this study is the very small sample size of only seven patients, which restricts the generalizability of the findings.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Uncategorised
Source Pubmed
PubMed ID 9083891
Year Published 1997
Journal Journal of clinical immunology
MeSH Terms Adult; Biomarkers; Crohn Disease; Female; Humans; Hyperbaric Oxygenation; Interleukin-1; Interleukin-6; Male; Middle Aged; Monocytes; Transforming Growth Factor alpha

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.